z-logo
open-access-imgOpen Access
Emtricitabine compared with lamivudine may preserve future therapeutic options in HIV-1-infected children
Author(s) -
Pierre Frange,
S. Blanche,
MarieLaure Chaix
Publication year - 2013
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkt215
Subject(s) - emtricitabine , lamivudine , resistance mutation , efavirenz , medicine , pharmacology , zidovudine , ritonavir , virology , viral load , biology , human immunodeficiency virus (hiv) , antiretroviral therapy , virus , genetics , viral disease , hepatitis b virus , reverse transcriptase , rna , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom